Overview

Corporate Profile

Laboratory Corporation of America® Holdings, an S&P 500 company, is the world’s leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people’s health by delivering the combination of world-class diagnostics, drug development and knowledge services. With combined revenue pro... More >>

Recent NewsMore >>
DateTitle 
05/19/16New Complementary Diagnostic Test Available from LabCorp for Treatment of Bladder Cancer
VENTANA PD-L1 (SP142) Assay Identifies Metastatic Patients with Urothelial Cancer that May Benefit from Treatment with TECENTRIQ® (atezolizumab) BURLINGTON, N.C.--(BUSINESS WIRE)--May 19, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) today announced the nationwide availability of the VENTANA PD-L1 (SP142) Assay as a complementary diagnostic for TECENTRIQ (atezolizumab), a new immunotherapy treatment for patien... 
Printer Friendly Version
05/09/16LabCorp Announces the Launch of the Epi proColon® Test for Colorectal Cancer Screening
First FDA-Approved Blood-Based Colorectal Cancer Test Offers Alternative for Patients Non-Compliant with Existing Screening Options BURLINGTON, N.C.--(BUSINESS WIRE)--May 9, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced the launch of Epi proColon®, a blood-based test for colorectal cancer screening that was approved on April 13, 2016 for clinical use by the U.S. Food and Drug Administration (FDA). Epi... 
Printer Friendly Version
05/06/16LabCorp to Webcast Its Annual Meeting of Stockholders
BURLINGTON, N.C.--(BUSINESS WIRE)--May 6, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that its Annual Meeting of Stockholders will be webcast live beginning May 11, 2016 at 9:00 a.m. Eastern Daylight Time via the Company website at www.labcorp.com. An archived replay of the audio webcast will be available for one year. About LabCorp® Laboratory Corporation of America® Holdings, an S&... 
Printer Friendly Version
04/25/16Laboratory Corporation of America® Holdings Announces 2016 First Quarter Results and Raises 2016 Guidance
Q1 Net revenue of $2.3 billion, up 30% over last year Q1 Diluted EPS of $1.55; Q1 Adjusted EPS of $2.02, up 15% over last year 2016 Adjusted EPS guidance raised to $8.55 – $8.95, up 8% to 13% over 2015 BURLINGTON, N.C.--(BUSINESS WIRE)--Apr. 25, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced results for the quarter ended March 31, 2016. “We... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
LH (Common)
ExchangeNYSE
Price$128.01
Change Stock is Up 0.70
Intraday High$128.39
Intraday Low$127.33
Volume406,391
Data as of 05/27/16
4:02 p.m. ET
Minimum 20 minute delay
Refresh quote

Reports & Performance

2014 Annual Report

2013 Annual Report

2012 Annual Report

2011 Annual Report

2010 Annual Report

2009 Annual Report

2008 Annual Report

2007 Annual Report

2006 Annual Report

Latest Earnings Release